Home

Dráma Elismertem hamisítvány henri termeer genzyme Póráz fordítás folyadék

69 Henri Termeer Photos and Premium High Res Pictures - Getty Images
69 Henri Termeer Photos and Premium High Res Pictures - Getty Images

Henri Termeer, 'giant of biotech' and longtime CEO of Genzyme, dies at 71 -  Boston Business Journal
Henri Termeer, 'giant of biotech' and longtime CEO of Genzyme, dies at 71 - Boston Business Journal

Former Head of Genzyme Dies | The Scientist Magazine®
Former Head of Genzyme Dies | The Scientist Magazine®

Former Genzyme CEO Henri Termeer co-founds biotech aimed at Parkinson's -  Boston Business Journal
Former Genzyme CEO Henri Termeer co-founds biotech aimed at Parkinson's - Boston Business Journal

Henri Termeer, 71, former CEO of Genzyme – Boston Herald
Henri Termeer, 71, former CEO of Genzyme – Boston Herald

Henri Termeer - Wikipedia
Henri Termeer - Wikipedia

Henri A. Termeer Tribute
Henri A. Termeer Tribute

New chief aims to remake Sanofi Genzyme - STAT
New chief aims to remake Sanofi Genzyme - STAT

MIT Corporation life member and biotech pioneer Henri Termeer dies at 71 |  MIT News | Massachusetts Institute of Technology
MIT Corporation life member and biotech pioneer Henri Termeer dies at 71 | MIT News | Massachusetts Institute of Technology

Henri Termeer, CEO Genzyme Corp, RIP | Boston Photographer Stanley Rowin
Henri Termeer, CEO Genzyme Corp, RIP | Boston Photographer Stanley Rowin

Henri Termeer, 71, former CEO of Genzyme – Boston Herald
Henri Termeer, 71, former CEO of Genzyme – Boston Herald

Here's the proposed design of the Henri Termeer statue and plaza in Kendall  Square - Boston Business Journal
Here's the proposed design of the Henri Termeer statue and plaza in Kendall Square - Boston Business Journal

مدیرعامل با سابقه حوزه بیوتکنولوژی، هنری ترمر(Henri Termeer) - بُن‌دا لَب -  شتابدهنده بن دا لب
مدیرعامل با سابقه حوزه بیوتکنولوژی، هنری ترمر(Henri Termeer) - بُن‌دا لَب - شتابدهنده بن دا لب

With sale, Genzyme CEO Henri A. Termeer reflects on building a biotech  pioneer - The Boston Globe
With sale, Genzyme CEO Henri A. Termeer reflects on building a biotech pioneer - The Boston Globe

New Book Details Singular Life of Biotech Pioneer, UVA Darden Alumnus Henri  Termeer – Darden Report Online
New Book Details Singular Life of Biotech Pioneer, UVA Darden Alumnus Henri Termeer – Darden Report Online

Genzyme's former CEO takes board seat at Moderna - Boston Business Journal
Genzyme's former CEO takes board seat at Moderna - Boston Business Journal

A tale of collaboration in which Henri Termeer helped steer policy changes  - ConvergenceRI
A tale of collaboration in which Henri Termeer helped steer policy changes - ConvergenceRI

Larger-than-life biotech figure Henri Termeer dies at 71 - MedCity News
Larger-than-life biotech figure Henri Termeer dies at 71 - MedCity News

Harvard Business School's Baker Library Announces New Collection: John  Hawkins Research Interviews about Henri Termeer, Longtime Chairman, CEO,  and President of Genzyme Corporation - News - Harvard Business School
Harvard Business School's Baker Library Announces New Collection: John Hawkins Research Interviews about Henri Termeer, Longtime Chairman, CEO, and President of Genzyme Corporation - News - Harvard Business School

Mission And Mentorship: The Health Care Legacy Of Henri Termeer | Health  Affairs
Mission And Mentorship: The Health Care Legacy Of Henri Termeer | Health Affairs

HENRI TERMEER Obituary (2017) - Marblehead, MA - Boston Globe
HENRI TERMEER Obituary (2017) - Marblehead, MA - Boston Globe

69 Henri Termeer Photos and Premium High Res Pictures - Getty Images
69 Henri Termeer Photos and Premium High Res Pictures - Getty Images

Henri Termeer To Leave Genzyme With About $160 Million | CHEManager
Henri Termeer To Leave Genzyme With About $160 Million | CHEManager

How Genzyme became a source of biotech executives - The Boston Globe
How Genzyme became a source of biotech executives - The Boston Globe

When science collides with stock market pressure - The Washington Post
When science collides with stock market pressure - The Washington Post